Revision surgeries are rising, and so are the risks.
Up to 10% of patients who have had a major joint replacement (hip, knee or shoulder) will need a joint revision every year. Amotio is emerging with a new unique patient specific surgical approach and medical device to reduce the complexity of procedures.
Transforming Revision Surgery
We have developed patient-specific solutions that set new standards in orthopaedic revision, empowering surgeons to operate with greater accuracy and confidence.
Precision for Better Outcomes
Our solutions reduce surgical time, improves bone preservation, and enhances patient recovery — delivering measurable improvements in care.
Trusted by Surgeons & Expert Design Engineers
Supported by clinical expertise and rigorous engineering, our solutions are designed in collaboration with leading surgeons and research institutions worldwide.
Market Opportunity & Early Traction
3 major NHS trusts are piloting Amotio’s technology. Our IP is protected by two filings (one granted). The UK, EU & USA market alone exceeds £2 billion annually, and our clinical advisory board includes leading surgeons and regulatory experts.
Investor RelationsFollow Us on LinkedIn
Stay up to date with our latest company news, events, and insights into the future of orthopaedic revision surgery.
Our Partners & Affiliations
Backed by trusted institutions in health innovation and investment.
Ready to Shape the Future of Orthopaedic Care?
Join our mission to make advanced revision surgery safer, faster, and accessible to every patient. Connect now to review pilot results, explore partnership, or invest in Amotio’s next chapter.